Atlas Trials

Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma

Clinical trial NCT00768937 · COMPLETED

Trial details

NCT number
NCT00768937
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2008-09-01
Primary completion
2010-10-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.